Pharmaceutical care is a healthcare practice that has been implemented recently worldwide. Its ai... more Pharmaceutical care is a healthcare practice that has been implemented recently worldwide. Its aim is the rational medication use and the achievement of desired therapeutic goals that improve the patient quality of life. This review see ks to define and relate the terms: pharmaceutical care, clinical pharmacy and pharmacotherapy follow-up, which are misunderstood in our field. Likewise, it seeks to show the transformation that has had this practice, from the traditional pharmacist (limited to the production and distribution of medicines) into the comprehensive pharmacist nowadays (active participant of interdisciplinary health teams and responsible for all the medication needs at a political, social and economic level). An approach of these terms to the National Health System context is also the goal of this review. Through this, it is intended to homologate the terminology of this practice in our country and to state future reflections and challenges that pharmacists and different ...
OBJECTIVE: to analyze the historical evolution of the concepts of Drug-Related Problems (DRP), Dr... more OBJECTIVE: to analyze the historical evolution of the concepts of Drug-Related Problems (DRP), Drug-related utilization problems (DRUP) and negative clinical outcomes (NCO) in order to unify the terminology at the national and international level, since confusion has been observed regarding the definitions of problems of process (causes) and problems of outcome (effects). Such issue may interfere with and have a negative impact on therapeutic goals.METHODOLOGY: a narrative literature review using the Medline and SciELO electronic databases in order to obtain information including the following concepts and terms: DRP, DRUP, nco. No restrictions by date of publication were set, and the search was carried out in Spanish and English.RESULTS: no consensus regarding the terms used with drug-related problems was found in the documents. In Decree 2200/2005 (Colombia), DRP are problems of drug use and negative outcomes of medication. Likewise, nco are the negative clinical outcomes of medic...
Background: Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence o... more Background: Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence of one or more manic episodes, or both depressive and manic episodes, usually separated by asymptomatic intervals. Pharmacists can contribute to the management of BD-I, mainly with the use of effective and safe drugs, and improve the patient's life quality through pharmaceutical care. Some studies have shown the effect of pharmaceutical care in the achievement of therapeutic goals in different illnesses; however, to our knowledge, there is a lack of randomized controlled trials designed to assess the effect of pharmacist intervention in patients with BD. The aim of this study is to assess the effectiveness of the Dader Method for pharmaceutical care in patients with BD-I. Methods/design: Randomized, controlled, prospective, single-center clinical trial with duration of 12 months will be performed to compare the effect of Dader Method of pharmaceutical care with the usual care process of patients in a psychiatric clinic. Patients diagnosed with BD-I aged between 18 and 65 years who have been discharged or referred from outpatients service of the San Juan de Dios Clinic (Antioquia, Colombia) will be included. Patients will be randomized into the intervention group who will receive pharmaceutical care provided by pharmacists working in collaboration with psychiatrists, or into the control group who will receive usual care and verbal-written counseling regarding BD. Study outcomes will be assessed at baseline and at 3, 6, 9, and 12 months after randomization. The primary outcome will be to measure the number of hospitalizations, emergency service consultations, and unscheduled outpatient visits. Effectiveness, safety, adherence, and quality of life will be assessed as secondary outcomes. Statistical analyses will be performed using two-tailed McNemar tests, Pearson chi-square tests, and Student's t-tests; a P value <0.05 will be considered as statistically significant.
Pharmaceutical care is a healthcare practice that has been implemented recently worldwide. Its ai... more Pharmaceutical care is a healthcare practice that has been implemented recently worldwide. Its aim is the rational medication use and the achievement of desired therapeutic goals that improve the patient quality of life. This review see ks to define and relate the terms: pharmaceutical care, clinical pharmacy and pharmacotherapy follow-up, which are misunderstood in our field. Likewise, it seeks to show the transformation that has had this practice, from the traditional pharmacist (limited to the production and distribution of medicines) into the comprehensive pharmacist nowadays (active participant of interdisciplinary health teams and responsible for all the medication needs at a political, social and economic level). An approach of these terms to the National Health System context is also the goal of this review. Through this, it is intended to homologate the terminology of this practice in our country and to state future reflections and challenges that pharmacists and different ...
OBJECTIVE: to analyze the historical evolution of the concepts of Drug-Related Problems (DRP), Dr... more OBJECTIVE: to analyze the historical evolution of the concepts of Drug-Related Problems (DRP), Drug-related utilization problems (DRUP) and negative clinical outcomes (NCO) in order to unify the terminology at the national and international level, since confusion has been observed regarding the definitions of problems of process (causes) and problems of outcome (effects). Such issue may interfere with and have a negative impact on therapeutic goals.METHODOLOGY: a narrative literature review using the Medline and SciELO electronic databases in order to obtain information including the following concepts and terms: DRP, DRUP, nco. No restrictions by date of publication were set, and the search was carried out in Spanish and English.RESULTS: no consensus regarding the terms used with drug-related problems was found in the documents. In Decree 2200/2005 (Colombia), DRP are problems of drug use and negative outcomes of medication. Likewise, nco are the negative clinical outcomes of medic...
Background: Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence o... more Background: Bipolar I disorder (BD-I) is a chronic mental illness characterized by the presence of one or more manic episodes, or both depressive and manic episodes, usually separated by asymptomatic intervals. Pharmacists can contribute to the management of BD-I, mainly with the use of effective and safe drugs, and improve the patient's life quality through pharmaceutical care. Some studies have shown the effect of pharmaceutical care in the achievement of therapeutic goals in different illnesses; however, to our knowledge, there is a lack of randomized controlled trials designed to assess the effect of pharmacist intervention in patients with BD. The aim of this study is to assess the effectiveness of the Dader Method for pharmaceutical care in patients with BD-I. Methods/design: Randomized, controlled, prospective, single-center clinical trial with duration of 12 months will be performed to compare the effect of Dader Method of pharmaceutical care with the usual care process of patients in a psychiatric clinic. Patients diagnosed with BD-I aged between 18 and 65 years who have been discharged or referred from outpatients service of the San Juan de Dios Clinic (Antioquia, Colombia) will be included. Patients will be randomized into the intervention group who will receive pharmaceutical care provided by pharmacists working in collaboration with psychiatrists, or into the control group who will receive usual care and verbal-written counseling regarding BD. Study outcomes will be assessed at baseline and at 3, 6, 9, and 12 months after randomization. The primary outcome will be to measure the number of hospitalizations, emergency service consultations, and unscheduled outpatient visits. Effectiveness, safety, adherence, and quality of life will be assessed as secondary outcomes. Statistical analyses will be performed using two-tailed McNemar tests, Pearson chi-square tests, and Student's t-tests; a P value <0.05 will be considered as statistically significant.
Uploads
Papers by andrea ospina